2min chapter

Blood Cancer Talks cover image

Episode 17. Acquired Aplastic Anemia

Blood Cancer Talks

CHAPTER

The Risk of Secondary Myelornia Plasms in Plastic Anemia

The risk after immunosuppressive therapy of secondary myeloid neoplasms has remained very real and very consistent. It's usually, depending on the series, between 10 and 20%. And the article that you refer to, which is some really beautiful work from Carmelo Granari in Yark Matsuyeski's lab, looked at a super large multi for a plastic anemia. These are rare diseases. Yeah, thousand patients, that's it. That's a big, big core. The median follow up was a little over eight and a half years.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode